Intel Raises Equity Offering to $20 Billion to Fund U.S. Fab Expansion

The move follows Intel's receipt of $8.5 billion in CHIPS Act grants and up to $11 billion in loans, committing the firm to new wafer fabs in Arizona, Ohio and Oregon. Primary SEC filings show proceeds will cover capital expenditures exceeding $100 billion through 2027. This capital structure choice avoids additional debt while satisfying U.S. government conditions for on-shore production, directly addressing documented supply-chain vulnerabilities exposed by 2021-2023 shortages.

U.S. policy incentives prioritize geographic diversification away from Taiwan and South Korea. Intel's dilution transfers ownership risk to new shareholders while securing state-backed financing that TSMC and Samsung have also accepted under similar export-control regimes. The transaction reveals the cost of alignment with Washington: equity issuance at depressed valuations after Intel's market share losses to AMD and foundry competitors.

Market data indicate Intel shares traded at multi-year lows prior to the announcement, amplifying the immediate ownership transfer. Future CHIPS disbursement tranches remain contingent on milestone compliance, including technology transfer restrictions toward Chinese entities. This structure locks Intel into sustained U.S. policy alignment regardless of commercial returns.

Next steps hinge on execution of the Arizona and Ohio sites and any revision to 2025 capex guidance. Failure to meet production targets could trigger clawback provisions in the CHIPS agreements, raising the effective cost of the equity raise.